Xellia Pharmaceuticals Inc., a leading global provider of specialty pharmaceuticals, is headquartered in the United States. Founded in 1908, the company has established a strong presence in the development and manufacturing of anti-infective and injectable products, primarily focusing on critical care and hospital settings. With operational facilities in Europe and North America, Xellia is renowned for its expertise in producing high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s core offerings include a range of injectable antibiotics and antifungal medications, distinguished by their efficacy and safety profiles. Xellia's commitment to innovation and quality has positioned it as a trusted partner in the healthcare industry, achieving notable milestones such as regulatory approvals and strategic collaborations. With a robust market presence, Xellia Pharmaceuticals continues to advance its mission of improving patient outcomes worldwide.
We don't have data for Xellia Pharmaceuticals Inc., but we can show you information about their parent organization instead.
View parent company